DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE VERSUS VINORELBINE AND CAPECITABINE IN PATIENTS NOT SUFFICIENTLY / SUFFICIENTLY RESPONDING AS PREOPERATIVE TREATMENT OF LOCALLY ADVANCED OR OPERABLE PRIMARY BREAST CANCER: